Nuvation Bio stock today: NUVB slides nearly 7% as early gains fade
Nuvation Bio shares fell 6.8% to $8.35 in Friday afternoon trading, reversing an early jump and underperforming major biotech ETFs. About 3.3 million shares traded hands. No new regulatory filings were reported. Investors are awaiting updates on IBTROZI’s commercial launch and clinical milestones.